This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.
Question 941
Topic: Biology, Genetics & Bone Healing
Which of the following growth factors is highly osteoinductive, signals via cell-surface serine/threonine kinase receptors to activate the SMAD intracellular pathway, and is FDA-approved for use in open tibia fractures?
Correct Answer & Explanation
. Bone morphogenetic protein-2 (BMP-2)
Explanation
Bone morphogenetic proteins (specifically BMP-2 and BMP-7) are potent osteoinductive growth factors belonging to the TGF-beta superfamily. They bind to serine/threonine kinase receptors and signal intracellularly via the SMAD pathway. rhBMP-2 is FDA approved for use in open tibia fractures and anterior lumbar interbody fusions (ALIF).
Question 942
Topic: Biology, Genetics & Bone Healing
A 30-year-old female presents with a lytic, expansile lesion in the distal femur extending to the subchondral bone. A core needle biopsy confirms a Giant Cell Tumor of bone. If medical therapy is considered, it would typically involve Denosumab. What is the precise mechanism of action of this drug?
Correct Answer & Explanation
. Monoclonal antibody that binds to and inhibits RANK ligand (RANKL)
Explanation
Denosumab is a fully human monoclonal antibody that binds directly to RANK Ligand (RANKL), preventing it from activating RANK on the surface of osteoclasts and their precursors. In Giant Cell Tumor of bone, the neoplastic stromal cells express high levels of RANKL, which recruits the giant cell osteoclasts that cause bone destruction. Denosumab effectively halts this osteoclastic bone resorption.
Question 943
Topic: Biology, Genetics & Bone Healing
Recombinant human bone morphogenetic protein-2 (rhBMP-2) signals primarily through serine/threonine kinase receptors. Which of the following intracellular signaling molecules is directly phosphorylated following rhBMP-2 receptor activation to initiate osteoblastic gene transcription?
Correct Answer & Explanation
. Smad 1/5/8
Explanation
Bone morphogenetic proteins (BMPs) belong to the TGF-beta superfamily. When rhBMP-2 binds to its dimeric serine/threonine kinase receptor, it triggers the intracellular phosphorylation of receptor-regulated Smads, specifically Smad 1, 5, and 8. These complex with Smad 4, translocate to the nucleus, and regulate the transcription of osteogenic genes like Runx2.
Question 944
Topic: Biology, Genetics & Bone Healing
Denosumab is often utilized in the medical management of surgically unsalvageable or recurrent Giant Cell Tumors of Bone (GCTB). What is the specific mechanism of action of this medication?
Correct Answer & Explanation
. Binding and inhibition of the RANK Ligand (RANKL)
Explanation
Giant Cell Tumor of Bone (GCTB) contains neoplastic mononuclear stromal cells that express high levels of RANK Ligand (RANKL). RANKL normally binds to RANK on osteoclast precursors, leading to massive osteoclast-like giant cell formation and bone destruction. Denosumab is a monoclonal antibody that binds to RANKL, preventing it from activating RANK, thereby potently inhibiting osteoclast-mediated bone resorption and stabilizing the tumor.
Question 945
Topic: Biology, Genetics & Bone Healing
Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction during fracture healing. Following the binding of BMPs to their serine/threonine kinase cell surface receptors, which family of intracellular signaling molecules is directly phosphorylated to translocate to the nucleus and regulate gene transcription?
Correct Answer & Explanation
. Smad
Explanation
BMPs signal primarily through the canonical Smad pathway. Binding of BMP to its heterodimeric serine/threonine kinase receptor complex leads to the phosphorylation of receptor-regulated Smads (R-Smads, such as Smad1, 5, and 8), which then complex with the common-partner Smad (Smad4) and translocate to the nucleus to regulate transcription of osteogenic genes.
Question 946
Topic: Biology, Genetics & Bone Healing
A 32-year-old female presents with a large, lytic, eccentrically located epiphyseal lesion in her distal femur. Biopsy reveals multinucleated giant cells in a background of mononuclear stromal cells. She is prescribed denosumab prior to surgical intervention to downstage the tumor. What is the precise mechanism of action of denosumab in treating this tumor?
Correct Answer & Explanation
. It is a monoclonal antibody that binds to RANKL on mononuclear stromal cells, preventing RANK receptor activation on osteoclast precursors
Explanation
In Giant Cell Tumor (GCT) of bone, neoplastic mononuclear stromal cells overexpress Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL), which recruits and activates the reactive multinucleated giant cells via their RANK receptors. Denosumab is a monoclonal antibody that binds directly to RANKL, preventing its interaction with RANK, thereby inhibiting osteoclast-like giant cell formation and reducing osteolysis.
Question 947
Topic: Biology, Genetics & Bone Healing
A 35-year-old woman is diagnosed with an aggressive giant cell tumor (GCT) of the distal radius. Due to the size and proximity to the joint, she is treated with neoadjuvant denosumab prior to surgical curettage. What is the specific mechanism of action of denosumab in the treatment of GCT of bone?
Correct Answer & Explanation
. It is a monoclonal antibody that binds to and inhibits RANKL.
Explanation
Denosumab is a fully human monoclonal antibody that binds directly to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). In Giant Cell Tumor of bone, the neoplastic mononuclear stromal cells express high levels of RANKL, which recruits and activates the reactive multinucleated giant cells (osteoclast-like cells) responsible for bone destruction. By inhibiting RANKL, denosumab stops the formation and activity of these destructive giant cells.
Question 948
Topic: Biology, Genetics & Bone Healing
In the pathogenesis of acute Charcot neuroarthropathy, pro-inflammatory cytokines play a critical role in increasing the expression of which of the following, leading to amplified osteoclastogenesis?
Correct Answer & Explanation
. RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand)
Explanation
In acute Charcot neuroarthropathy, the inflammatory cascade leads to an over-expression of RANKL relative to OPG. This imbalance drives unchecked osteoclastic bone resorption, resulting in the classic osteopenia and bone fragmentation seen in the acute phase.
Question 949
Topic: Biology, Genetics & Bone Healing
Denosumab is highly effective in the management of unresectable Giant Cell Tumor (GCT) of bone. What is the specific cellular target of this monoclonal antibody?
Correct Answer & Explanation
. RANK Ligand (RANKL)
Explanation
Denosumab is a fully human monoclonal antibody that binds to RANKL, preventing it from activating RANK on the surface of osteoclasts and their precursors. In GCT, the neoplastic mononuclear stromal cells express RANKL, which recruits and activates the reactive multinucleated giant cells responsible for aggressive bone resorption.
Question 950
Topic: Biology, Genetics & Bone Healing
Bone morphogenetic proteins (BMPs) play a crucial role in osteoblast differentiation and bone formation. Which of the following best describes the intracellular signaling pathway activated immediately upon BMP-2 binding to its serine/threonine kinase cell surface receptor?
Correct Answer & Explanation
. Phosphorylation of Smad 1/5/8 proteins
Explanation
BMPs bind to dimeric transmembrane serine/threonine kinase receptors. This binding causes phosphorylation and activation of receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These then form a complex with the co-Smad (Smad 4), which translocates into the nucleus to regulate the transcription of osteogenic target genes like Runx2.
Question 951
Topic: Biology, Genetics & Bone Healing
A 35-year-old female presents with a large, destructive lytic lesion in her distal radius with cortical breakthrough. Biopsy confirms a Giant Cell Tumor (GCT) of bone. Neoadjuvant therapy with denosumab is considered to downstage the tumor prior to curettage. What is the specific mechanism of action of denosumab in treating this lesion?
Correct Answer & Explanation
. It is a monoclonal antibody that binds directly to RANKL, preventing osteoclast activation
Explanation
Denosumab is a fully human monoclonal antibody that binds directly to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). In Giant Cell Tumor of bone, the neoplastic mononuclear stromal cells overexpress RANKL, which recruits and activates the reactive multinucleated giant cells (osteoclast-like cells) responsible for bone destruction. Denosumab inhibits this interaction.
Question 952
Topic: Biology, Genetics & Bone Healing
A 25-year-old woman is diagnosed with a giant cell tumor (GCT) of the distal femur. Her surgeon considers neoadjuvant treatment with Denosumab prior to curettage to facilitate intralesional resection. What is the exact mechanism of action of Denosumab?
Correct Answer & Explanation
. Monoclonal antibody against RANKL
Explanation
Denosumab is a fully human monoclonal antibody that binds directly to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL), preventing it from binding to the RANK receptor on osteoclasts and their precursors. This effectively inhibits osteoclast-mediated bone destruction, which is the primary driver of osteolysis in Giant Cell Tumor of bone.
Question 953
Topic: Biology, Genetics & Bone Healing
Demineralized bone matrix (DBM) is commonly used in orthopedic procedures as a bone graft extender. Processing allograft bone into DBM preserves which primary biologic property for bone healing?
Correct Answer & Explanation
. Osteoinduction
Explanation
Demineralized bone matrix (DBM) undergoes acid extraction of the mineralized phase, which exposes bone morphogenetic proteins (BMPs) and other growth factors. This confers osteoinductive properties to the graft. Because it lacks live cells, it is not osteogenic. While it provides minimal osteoconductive scaffold, its primary therapeutic advantage over cancellous chips is osteoinduction.
Question 954
Topic: Biology, Genetics & Bone Healing
Bone Morphogenetic Proteins (BMPs) play a crucial role in osteoinduction and fracture healing. Biologically, BMPs are members of which of the following larger signaling superfamilies?
Correct Answer & Explanation
. Transforming Growth Factor-beta (TGF-beta)
Explanation
Bone Morphogenetic Proteins (BMPs) are a group of growth factors structurally classified as part of the Transforming Growth Factor-beta (TGF-beta) superfamily. They bind to serine/threonine kinase receptors on the cell surface and mediate downstream signaling via Smad proteins to induce differentiation of mesenchymal stem cells into osteoblasts.
Question 955
Topic: Biology, Genetics & Bone Healing
During the incorporation of a cortical bone allograft, what is the term used to describe the process where osteoclasts resorb the dead bone and osteoblasts simultaneously lay down new bone in the cutting cone?
Correct Answer & Explanation
. Creeping substitution
Explanation
Creeping substitution is the process by which cortical bone grafts are incorporated. It involves a cutting cone of osteoclasts resorbing the necrotic host bone, closely followed by osteoblasts depositing new viable bone along the pathways.
Question 956
Topic: Biology, Genetics & Bone Healing
Vitamin D plays a critical role in bone metabolism. Following synthesis in the skin or absorption from the gut, it undergoes two sequential hydroxylations to become biologically active. Which specific enzyme is responsible for the final conversion to 1,25-dihydroxyvitamin D (calcitriol)?
Correct Answer & Explanation
. 1-alpha-hydroxylase in the kidney
Explanation
Vitamin D is first hydroxylated in the liver by 25-hydroxylase to form 25-hydroxyvitamin D (calcidiol). The final, rate-limiting hydroxylation occurs in the proximal tubules of the kidney, catalyzed by the enzyme 1-alpha-hydroxylase, which converts it to 1,25-dihydroxyvitamin D (calcitriol), its most active form. This step is stimulated by PTH.
Question 957
Topic: Biology, Genetics & Bone Healing
A 68-year-old male presents with a pathologic fracture of the proximal humerus. Radiographs reveal a large 'punched-out' lytic lesion. Laboratory workup shows hypercalcemia, an elevated serum creatinine, and a monoclonal spike on serum protein electrophoresis (SPEP). In the pathophysiology of this disease, what is the primary mechanism driving the extensive osteolysis?
Correct Answer & Explanation
. Increased osteoclast activity driven by tumor cell secretion of RANKL and MIP-1 alpha
Explanation
The patient has Multiple Myeloma. The characteristic osteolytic bone lesions in multiple myeloma are driven by marked osteoclast activation combined with osteoblast inhibition. Myeloma cells do not destroy bone directly; instead, they secrete various factors, most notably RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand) and MIP-1 alpha (Macrophage Inflammatory Protein-1 alpha), which potently stimulate osteoclast differentiation and activity. They also suppress osteoblast function via DKK-1.
Question 958
Topic: Biology, Genetics & Bone Healing
According to Perren's strain theory, what is the required microstrain environment at the fracture site to promote primary (osteonal) bone healing?
Correct Answer & Explanation
. Less than 2%
Explanation
Perren's strain theory states that primary (osteonal) bone healing occurs under conditions of absolute stability, which corresponds to a local tissue strain of less than 2%. Secondary bone healing (callus formation) occurs in a relatively stable environment with strain between 2% and 10%.
Question 959
Topic: Biology, Genetics & Bone Healing
When selecting a bone graft or substitute for an osseous defect, which of the following materials possesses osteoinductive, osteoconductive, and osteogenic properties?
Correct Answer & Explanation
. Cancellous autograft
Explanation
Autograft is the only bone graft material that possesses all three essential properties for bone healing: osteoconduction (provides a physical scaffold), osteoinduction (provides growth factors like BMPs to stimulate differentiation), and osteogenesis (supplies live osteoblasts and mesenchymal stem cells).
Question 960
Topic: Biology, Genetics & Bone Healing
Bone morphogenetic proteins (BMPs) play a critical role in osteoinduction and fracture healing. Following the binding of BMP-2 to its transmembrane serine/threonine kinase receptor, which of the following intracellular signaling molecules is phosphorylated to translocate to the nucleus and initiate transcription of osteogenic genes?
Correct Answer & Explanation
. SMAD 1/5/8
Explanation
BMP signaling operates primarily through the SMAD pathway. When BMP binds to its serine/threonine kinase receptor, it phosphorylates receptor-regulated SMADs (specifically SMAD 1, 5, and 8). These then form a complex with the co-SMAD (SMAD 4), which translocates to the nucleus to regulate the transcription of target genes necessary for osteoblast differentiation.
Test Yourself
Switch to an interactive, timed exam simulation to truly master this topic.